Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1990
11/14/1990EP0396903A2 Use of IFN-gamma for the preparation of a pharmaceutical composition for the treatment of ATL
11/14/1990EP0396777A1 Interferon preparation for nasal administration
11/14/1990EP0396733A1 Improved extraction methods for preparing thromboplastin reagents.
11/14/1990EP0396709A1 Human leukocyte elastase inhibitors and methods of producing and using same
11/14/1990EP0396664A1 New derivatives of human/bovine basic fibroblast growth factor
11/14/1990EP0396552A1 Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception
11/13/1990US4970300 Conjugate with ligand; longer half-life
11/13/1990US4970299 Monoclonal antibodies selective for prostate cancer
11/13/1990US4970297 Transglutaminase inhibitors
11/13/1990US4970296 Units composed of signal peptide, transmembrane, and cytoplasmic segments
11/13/1990US4970207 Cholecystokinin antagonists
11/13/1990US4970159 Human tissue plasminogen activator consisting essentially of t-PA residues 160 to 527
11/13/1990US4970156 Immobilization of active protein by cross-linking to inactive protein
11/13/1990US4970076 And cyclosporin
11/13/1990US4970071 Immunotherapeutic methods and compositions employing antigens characteristic of non human malignant neoplasms
11/13/1990US4970070 Protective monoclonal antibody compositions for infections due to group B streptococcus
11/13/1990US4969912 Human collagen processing and autoimplant use
11/13/1990CA1276399C Peptides
11/13/1990CA1276398C Bursopoietin
11/13/1990CA1276397C Peptide derivatives having a lactonic or cycloaminic structure and process for their preparation
11/13/1990CA1276393C Aliphatic thioethers
11/13/1990CA1276392C Phosphonamidate compounds
11/13/1990CA1276390C Peptides
11/13/1990CA1276119C Monoclonal hybridoma and corresponding antibody
11/13/1990CA1276108C Process for modifying ribosome-inactivating glycoproteins by oxidation of their osidic units and formation of a schiff's base
11/12/1990CA2016439A1 N-phenyl amides, process for their preparation and medicaments containing same
11/11/1990WO1990013645A1 Production in bacteria and yeast of hemoglobin and analogues thereof
11/11/1990WO1990013641A1 Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
11/11/1990CA2055435A1 Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
11/11/1990CA2016387A1 High level expression of functional human plasminogen activator inhibitor (pai-1) in e. coli
11/11/1990CA2016355A1 Cyclopeptides
11/10/1990WO1990013308A1 TREATMENT OF MOTILITY DISORDERS WITH A GnRH ANALOG
11/10/1990CA2016385A1 Tumor-associated antigen, antibodies, compositions and uses therefor
11/09/1990CA2016049A1 Enzymatic removal of a protein amino-terminal sequence
11/08/1990DE4014230A1 Bombesin-antagonisten Bombesin antagonists
11/08/1990CA2016209A1 Fluoro-amide derivatives
11/08/1990CA2016208A1 Peptide derivatives
11/08/1990CA2016183A1 Polypeptides of feline t-cell lymphotropic lentivirus
11/08/1990CA2016165A1 Stabilization of organic compounds
11/07/1990EP0396505A2 Monoclonal antibodies specific for an immunoglobulin isotype
11/07/1990EP0396402A2 Cell growth activators
11/07/1990EP0396158A1 Production of pluripotent granulocyte colony-stimulating factor
11/07/1990EP0396065A1 Novel amino acid derivatives possessing renin-inhibitory activities
11/07/1990EP0395918A2 Plasminogen activator complex of pure pro-urokinase covalently bound by a disulfide bridge to human serum albumin
11/07/1990EP0395851A1 Avena sativa glycoproteins, procedure for obtaining them, and their use as medicines
11/07/1990EP0395669A1 Mouse monoclonal antibodies raised to the t-cell line hsb-2 and t-cell chronic lymphocytic leukemia (t-cll) cells react with normal human t and b lymphocytes and monocytes
11/07/1990EP0395664A1 Renin inhibitors containing a (1-amino-2-hydroxy-2-heterocyclic) ethyl moiety
11/07/1990EP0174978B1 Method of prophylaxis or treatment of atherosclerosis
11/06/1990US4968696 N,N'-bis-L-amino acid-L-cystine-peptide containing amino acid preparations for oral parenteral nutrition
11/06/1990US4968671 Therapeutic agents for ischemic heart diseases
11/06/1990US4968669 Parathyroid hormone antagonists
11/06/1990US4968617 Solid hydrochloride salt of t-PA
11/06/1990US4968616 Superoxide dismutase derivatives, method of producing same and medicinal use of same
11/06/1990US4968614 Obtained by genetic engineering
11/06/1990US4968608 Process for antifungal fermentation product
11/06/1990US4968607 Interleukin-1 receptors
11/06/1990US4968603 Prognosis of survival by measuring copies of oncogene in breast and ovarian cancers
11/06/1990US4968590 Surgical implants
11/06/1990US4968495 Chemically modified bilirubin oxidase
11/06/1990US4968494 Methods and compositions for thrombolytic therapy
11/06/1990CA1275953C Recombinant materials and methods for producing human connective tissue-activating peptide-iii and analogs thereof
11/06/1990CA1275952C Monoclonal antibodies against metal chelates
11/06/1990CA1275951C Lysing or blocking unwanted cells
11/06/1990CA1275950C Method for the production of human t-t cell hybridomas and production of suppressor factor by human t-t cell hybridomas
11/06/1990CA1275922C Treatment of cancer
11/05/1990WO1990013659A1 Processes and compositions for the isolation of human relaxin
11/05/1990WO1990013568A1 Antimetastatic peptides
11/05/1990CA2030798A1 Antimetastatic peptides
11/04/1990WO1990013630A1 Highly cytopathogenic hiv-ndk retrovirus, dna fragments of this retrovirus, method for preparing a protein and/or an enzyme of this virus, and the applications of these
11/04/1990CA2054720A1 Highly cytopathogenic hiv-ndk retrovirus, adn fragments thereof, process for the preparation of a protein and/or enzyme thereof and uses thereof
11/04/1990CA2015888A1 Monoclonal antibodies specific for an immunoglobulin isotype
11/04/1990CA2015862A1 Cell surface antigen that binds with l6 monoclonal antibody
11/03/1990WO1990013310A1 Improved forms of basic fibroblast growth factor
11/03/1990CA2055462A1 Improved forms of basic fibroblast growth factor
11/02/1990CA2015827A1 Amino acid derivatives possessing renin-inhibitory activities
11/02/1990CA2015768A1 Treatment of glaucoma
11/01/1990WO1990012892A1 Human intestinal mucin
11/01/1990WO1990012885A1 Monoclonal antibody for differentiation of squamous cell carcinoma antigens and method of use for same
11/01/1990WO1990012882A1 Herpes virus recombinant poxvirus vaccine
11/01/1990WO1990012881A1 Human recombinant placental ribonuclease inhibitor and method of production
11/01/1990WO1990012879A2 Expression of human apolipoproteins ai-milano in yeast
11/01/1990WO1990012874A2 Cysteine added variants of polypeptides and chemical modifications thereof
11/01/1990WO1990012867A1 Invasive microorganisms
11/01/1990WO1990012866A1 Lytic peptides, use for growth, infection and cancer
11/01/1990WO1990012815A1 Therapeutic compounds, compositions and uses thereof
11/01/1990WO1990012814A1 Hepatospecific insulin analogues
11/01/1990WO1990012813A1 Regulatory proteins
11/01/1990WO1990012811A1 Linear somatostatin analogs
11/01/1990WO1990012810A1 Grf analogs viia
11/01/1990WO1990012806A1 Synthetic peptides of the conjugate of ubiquitine and histone h2a
11/01/1990WO1990012805A1 Postostatin and related compound thereof, or their salts
11/01/1990WO1990012804A2 Peptides having novel polar n-terminal groups
11/01/1990WO1990012594A1 Novel monoclonal antibody to novel antigen associated with human tumors
11/01/1990WO1990012593A1 Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof
11/01/1990WO1990012590A1 Treatment of ocular disease by modulation of matrix metalloproteinases and their inhibitor
11/01/1990WO1990012589A1 New use of somatostatin
11/01/1990WO1990012588A1 Treatment and prevention of oral mucositis with growth factors
11/01/1990WO1990012587A1 Composition and treatment with biologically active peptides and antibiotic
11/01/1990WO1990012504A1 Inhibitors of agonist-specific desensitization
11/01/1990WO1990010705A3 Production and purification of recombinant human interleukin-3 and muteins thereof